Rüçhan Uslu

3.6k citations
147 papers · 2.6k · 1 hit paper · h-index 27

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Cancer survivorship and care
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Research Studies
    • Cancer Cells and Metastasis

Papers in

    • Cancer Treatment and Pharmacology 15
    • Colorectal Cancer Treatments and Studies 12
    • HER2/EGFR in Cancer Research 9
    • Cancer survivorship and care 9
    • Retinoids in leukemia and cellular processes 8

Rüçhan Uslu

137 papers receiving 2.5k citations

Rüçhan Uslu's Hit Papers

Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study 2018 · 345 citations
3450+2+5Years since publication100200300

Peers

Rüçhan Uslu
Comparison fields: 5 of 135
  • Oncology 1.1k
  • Cancer Research 238
  • Toxicology 55
  • Complementary and alternative medicine 96
  • Pulmonary and Respiratory Medicine 340
Replace Sergio Huerta with:
Sergio Huerta United States
Heather Shaw United States
Subhankar Chakraborty United States
Hong Yan China
Yoshiharu Motoo Japan
Paul R. Hutson United States
Mark Clemons Canada
Channing J. Paller United States
Floris A. de Jong Netherlands
Yi Sun China
Rüçhan Uslu relative to Sergio Huerta United States Sergio Huerta's profile →
Citations per field
00.5×3.2×
Sergio Huerta · 1×
Citations per year

Countries citing papers authored by Rüçhan Uslu

Since Specialization
Citations

This map shows the geographic impact of Rüçhan Uslu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rüçhan Uslu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rüçhan Uslu more than expected).

Fields of papers citing papers by Rüçhan Uslu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rüçhan Uslu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rüçhan Uslu. The network helps show where Rüçhan Uslu may publish in the future.

Co-authors

The 25 scholars most cited alongside Rüçhan Uslu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rüçhan Uslu Line = papers co-authored together Rüçhan Uslu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 147 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study
Hit paper breakdown →
2018345
2
Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines.
2000173
3
Effects of pilates exercises on functional capacity, flexibility, fatigue, depression and quality of life in female breast cancer patients: a randomized controlled study.
2010143
4 2013100
5 200964
6 201462
7
Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
199758
8 201355
9 201855
10 201447
11 201447
12 201745
13 201245
14 202141
15 200839
16 199639
17 201038
18 201338
19 201237
20 200935

About Rüçhan Uslu

Rüçhan Uslu is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Plant Science, having authored 147 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (15 papers), Colorectal Cancer Treatments and Studies (12 papers), Breast Cancer Treatment Studies (10 papers), Research in Cotton Cultivation (10 papers), HER2/EGFR in Cancer Research (9 papers), Prostate Cancer Treatment and Research (9 papers), Cancer survivorship and care (9 papers) and Retinoids in leukemia and cellular processes (8 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (238 citations), Toxicology (55 citations), Complementary and alternative medicine (96 citations) and Pulmonary and Respiratory Medicine (340 citations). Rüçhan Uslu has collaborated with scholars based in Türkiye, United States and South Korea. Frequent co-authors include Burçak Karaca, Bülent Karabulut, Harika Atmaca, Sibel Eyigör, Canfeza Sezgin, Aslı Kısım, Selim Uzunoğlu, Erdem Göker, Hilal Yeşil and Emir Bozkurt. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Gynecological Cancer, Molecular Biology Reports, Medical Oncology and British Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact